Full-Time

Regulatory Strategy Vice President

Vice President

Premier Research International

Premier Research International

1,001-5,000 employees

Contract research organization for clinical development

Compensation Overview

$200k/yr

Boston, MA, USA + 1 more

More locations: San Francisco, CA, USA

Remote

Bachelor's, Master's, PharmD, PhD

Category
Legal & Compliance (1)
Required Skills
Risk Management
Marketing

Get referred to Premier Research International

See people who can refer or advise you

Requirements
  • A minimum BS or MS degree in a science-related field.
  • A minimum of fifteen years of regulatory experience in the pharmaceutical, contract research organization, biotechnology, or consulting industry, including regulatory submissions in drug development, with at least seven years in a regulatory affairs management position.
  • A minimum of ten years of experience managing a team.
Responsibilities
  • Supervise, mentor, and motivate reporting associates; conduct performance reviews and participate in hiring new staff as needed.
  • Develop and implement strategic plans and objectives aligned with corporate strategy and revenue targets for high-quality regulatory services within specific geographies, regulatory pathways, or therapeutic areas.
  • Participate in developing corporate methods, techniques, and evaluation criteria for projects, programs, and people, including client budgets, staff oversight, productivity targets, employee timekeeping, and client invoice review and approval.
  • Consult and advise using expert knowledge of laws, regulations, and guidelines governing clinical trials in the United States, Europe, and other countries, as well as preclinical, chemistry, manufacturing and controls, and clinical development requirements for clinical trials and marketing authorization of new drugs.
  • Develop and maintain working relationships with the Food and Drug Administration, European Medicines Agency, and other regulators and government regulatory agencies to execute international and regional strategies, including United States 505(b)(1) and 505(b)(2) applications and global equivalents.
  • Provide leadership in preparing regulatory strategies, reviewing clinical development plans, producing regulatory submission materials, and interacting with health authorities for clients.
  • Provide strategic and tactical guidance to clients, senior management, and project teams to drive backlog and revenue growth across consulting services while supporting timely and efficient clinical development programs and regulatory compliance.
  • Partner with Business Development to cross-sell clinical contract research organization services and support Marketing-led campaign development and execution with content development expertise.
  • Present at applicable industry engagements and partner with Marketing to develop resources such as blogs and data sets.
  • Perform additional duties and assignments as requested.
Desired Qualifications
  • A PharmD or PhD degree is preferred.
  • Experience preparing regulatory submissions in the United States and/or Europe is required.
  • Experience with supervisory and financial management responsibilities in a regulatory affairs department of a contract research organization, pharmaceutical or biotechnology company, or consulting firm.
  • Experience working in multidisciplinary project teams.
  • Demonstrated skills in complex reasoning, risk management, risk-benefit and cost-benefit assessments.
  • Demonstrated in-depth knowledge of applicable laws, regulations, and guidelines covering clinical trials and regulatory applications in International Council for Harmonisation territories, including preclinical, chemistry, manufacturing and controls, and clinical development regulations in the United States and worldwide.
  • Demonstrated track record of successful Food and Drug Administration Investigational New Drug applications and product approvals, or applicable international equivalents.
  • Excellent written and verbal communication and presentation skills, with the ability to persuade and influence.
  • Excellent interpersonal, motivational, and team-building skills.
  • Demonstrated scientific acumen in the designated functional or therapeutic domain.
Premier Research International

Premier Research International

View

Premier Research provides specialized clinical development services for biotech and specialty pharma, focusing on specific therapeutic areas where science is advancing. It supports end-to-end clinical trials, including study design, site management, data handling, statistics, regulatory affairs, and medical writing, across more than 20 countries with about 1,500 employees. Customers partner with Premier Research to plan and run development programs with cross-functional teams that design trials, manage sites and data, analyze results, and prepare regulatory submissions. The company aims to help biotech and pharma bring safe, effective therapies to patients faster by delivering high-quality clinical development and regulatory support.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$79.2M

Headquarters

Morrisville, North Carolina

Founded

1989

Get referred to Premier Research International

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Premier named Siân Ratcliffe Smethurst COO on January 6, 2026, sharpening operations.
  • Premier hired Paul Spreen as CCO on April 7, 2026, boosting enterprise selling.
  • Daré extended its exclusive U.S. CRO partnership on August 20, 2025, signaling client retention.

What critics are saying

  • Revelio shows roughly flat headcount in March 2026 and fewer 2026 postings.
  • IQVIA, ICON, and Parexel squeeze pricing, talent, and sponsor attention across CRO deals.
  • Biotech sponsor pullbacks delay studies; Premier's revenue concentration makes that an existential contract-loss risk.

What makes Premier Research International unique

  • Premier Research focuses on biotech, specialty pharma, and medtech, not commoditized mega-pharma work.
  • Its 20-country footprint combines clinical operations, regulatory strategy, and product development.
  • 2026 leadership additions, including John Ratliff and Siân Ratcliffe Smethurst, reinforce execution depth.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

17%
PR Newswire
Apr 7th, 2026
Premier Research appoints Paul Spreen as chief commercial officer

Premier Research, a global clinical research and product development company, has appointed Paul Spreen as Chief Commercial Officer. Spreen brings over 25 years of life sciences leadership experience and will oversee global commercial strategy, business development, marketing and proposals. Spreen previously served as EVP and Chief Commercial Officer at IQVIA (formerly Quintiles), where he held several global leadership positions. His experience spans the full drug development lifecycle, from early discovery through commercialisation, with a focus on scaling organisations during periods of rapid growth and M&A. In his new role, Spreen will drive sustainable growth, strengthen customer engagement and advance Premier's position across the drug development spectrum. The Morrisville, North Carolina-based company specialises in clinical trials and regulatory strategy for the biotechnology sector.

PharmiWeb
Apr 2nd, 2025
Premier Research Expands Clinical Leadership Team With Addition Of Milena Kanova-Petrova, Md, Global Head Of General Medicine

MORRISVILLE, NC, April 1, 2024 – Premier Research is pleased to announce the addition of Dr. Milena Kanova-Petrova as Senior Vice President, Global Head of General Medicine. In this role, Dr. Kanova-Petrova will oversee strategic planning and project execution for all general medicine clinical operations inclusive of internal medicine, women’s health and dermatology.“Our customers are breaking barriers and forging new pathways every day in the pursuit of bettering patient care. The work is complex and specialized, and adding Dr. Kanova-Petrova to our Clinical Leadership Team expands the specialization that we can provide to our customers,” said Premier Research Chief Operating Officer, Michael Arlotto, Ph.D

Labiotech
Jun 13th, 2024
From Ai To Telemedicine: Transforming Clinical Trial Recruitment In 2024

Recruitment is essential for generating data on drug efficacy, which is crucial for the approval of new medical treatments. Clinical trial success hinges on the ability to recruit a sufficient and appropriate number of participants. As Cara Brant, chief executive officer (CEO) of Clinical Trial Media puts it, “Trials are intended to generate data on how a drug works and you can’t generate that data if you don’t have participants in the study. This makes recruitment one of the linchpins of clinical research and drug development as a whole.”However, the landscape of clinical trial recruitment is becoming increasingly competitive. With over 450,000 clinical trials in progress globally, according to Brant. The task of recruiting participants has never been more challenging​​

TrialHub
Jan 31st, 2024
Shaping Patient-Centric Healthcare: Premier Research Collaborates with FindMeCure's TrialHub to Educate Patients About Clinical Research

TrialHub, a leading platform for patient feasibility in clinical trials, is proud to announce its collaboration with Premier Research.

PR Newswire
Jan 8th, 2024
Premier Research And Biocentriq Enter A Strategic Partnership To Accelerate Pre-Ind Timelines And Clinical Translation Of Innovative Cell Therapies

MORRISVILLE, N.C. and NEWARK, N.J., Jan. 8, 2024 /PRNewswire/ -- Premier Research, a preeminent global clinical research, product development, and consulting company, and BioCentriq, a renowned Contract Development and Manufacturing Organization (CDMO), have entered a strategic partnership to revolutionize the pre-Investigational New Drug (IND) process and accelerate the clinical translation of novel cell therapy products.Premier Research/BioCentriq LogoBy leveraging Premier Research's expertise in cell therapy product development and BioCentriq's proficiency in developing and manufacturing and testing cell therapies, the partnership will streamline the process of bringing new products to patients. As partners, Premier and BioCentriq are well positioned to support sponsors seeking to expedite the transition of their innovative cell therapy candidates from research to clinical trials."Partnering with BioCentriq aligns with our commitment to expediting the development of transformative cell therapies," stated Kenneth Ndugga-Kabuye, MD, FACMG, Vice President, Cell and Gene Therapy at Premier Research. "By merging our comprehensive product development expertise with BioCentriq's specialized capabilities we will help sponsors simplify the development process from pre-IND through approval, ultimately accelerating the delivery of innovative therapies to patients in need."This collaboration will harness Premier Research's comprehensive understanding of regulatory requirements, clinical trial design and study execution, alongside BioCentriq's specialized capabilities in cell therapy development."Cell therapy development is extremely complex," added Olu Aloba, PhD, Vice President, Chemical Manufacturing and Control (CMC) Services, Premier Consulting, a business unit of Premier Research, "Nonclinical and Clinical development, CMC, and the CDMO have to work hand in hand to address the scientific, logistical and regulatory demands that enable studies to generate high-quality results.""This collaboration marks a significant step in fostering a more streamlined pathway for groundbreaking cell therapies," remarked Alex Klarer, Vice President, Business Strategy and Innovation at BioCentriq. "Combining Premier Research's clinical insights with our CDMO expertise will empower us to expedite the translation of novel therapies from the lab to clinical reality, benefiting patients worldwide."About Premier ResearchPremier Research, a global clinical research, product development, and consulting company, is dedicated to helping biotech, specialty pharma, and medtech innovators transform life-changing ideas and breakthrough science into new medical treatments.Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.Whether it's developing product lifecycle strategies, reducing clinical development cycle timelines, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions